Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Enhanced expert advice for developers of AMR medicines

Written by | 7 Dec 2025

Companies developing medicines or vaccines targeting antimicrobial resistance (AMR) can now avail of improved scientific advice from the European Medicines Agency (EMA). The new approach brings together expertise… read more.

Green light for 10 new medicines in November 2025

Written by | 7 Dec 2025

The European Medicines Agency’s key committee on human medicines (CHMP) recommended ten medicines for approval at its November 2025 meeting. This brings to 97 the total number of… read more.

EMA teams up with influencers on weight loss drugs

Written by | 6 Dec 2025

The EU drug watchdog, the European Medicines Agency (EMA), has launched a partnership with social media influencers to promote the safe use of GLP-1 receptor agonists. The #HealthNotHype… read more.

EU green light for 13 new medicines in June

Written by | 28 Jun 2025

The European Medicines Agency’s (EMA) key expert group has recommended 13 medicines for approval at its June 2025 meeting. The Committee on Medicinal Products for Human Use (CHMP)… read more.

Green light for 16 new medicines in the EU

Written by | 22 May 2025

April was a bumper month for drug approvals in Europe, with sixteen new products recommended by the European Medicines Agency’s (EMA) key committee on human medicines. This almost… read more.

EU renews mandate of drug watchdog chief

Written by | 20 May 2025

The European Medicines Agency (EMA) looks set to extend the contract of its Executive Director, Emer Cooke. The Agency’s Management Board unanimously recommended renewing her mandate at a… read more.

Green light for four new medicines in the EU

Written by | 9 Mar 2025

The European Medicines Agency (EMA) has recommended four new products for approval, and extended the use of sixteen other drugs. The decisions, which brings to 12 the total… read more.

EU launches new map of clinical trials

Written by | 8 Mar 2025

A new clinical trial map has been developed and published as part of the Accelerating Clinical Trials in the European Union (ACT EU) initiative. The map is accessible… read more.

EMA approves 17 medicines at December meeting

Written by | 28 Dec 2024

The European Medicines Agency rounded off a busy year by approving seventeen new medicines. At its December meeting, the Committee for Medicinal Products for Human Use (CHMP) also… read more.

EU drug regulators agree common approach to data transparency

Written by | 27 Dec 2024

The European Medicines Agency (EMA) and Heads of Medicines Agencies (HMA) have published a comprehensive overhaul of their guidance on the identification of commercially confidential information (CCI) and… read more.

EU approved 114 medicines in 2024

Written by | 26 Dec 2024

The European Medicines Agency has approved more than 100 new medicines for the first time in fifteen years. Of the 114 medicines given the green light in 2024,… read more.

EU drug watchdog rewrites conflict of interest rules

Written by | 4 Nov 2024

The European Medicines Agency (EMA) is revising its ‘competing interests’ policy for experts and members of scientific committees. The new rules are expected to be adopted by the… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.